properties with low immunogenicity and the infiltration of T cells. [3] Therefore, strategies by which "cold" tumors can be transformed into "hot" tumors have been extensively researched so that more patients may obtain the benefits of ICBs therapy. The immunogenic cell death (ICD) of tumors has been proved to be an effective tool to improve the immunogenicity of tumor cells. [4] ICD occurs when specific inducers harness the host immune system to recognize and kill cancer cells by causing endoplasmic reticulum (ER) stress. [5] The dying tumor cells release damage-associated molecular patterns (DAMPs), which primarily consist of calreticulin (CRT), high mobility group box 1 (HMGB1), adenosine triphosphate (ATP), and heat shock protein 70 (HSP70). [6] Previous literature revealed that the antigen presentation efficiency of dendritic cells (DCs) was positively correlated with the DAMP content in tumors; [7] therefore, the sufficient release of DAMPs from tumor cells undergoing ICD is crucial to improve immunotherapy efficiency. Apart from the low immunogenicity of tumor cells, the counteracted innate immune system is also responsible for the poor therapeutic effect of ICBs. The suppressive immune cells in tumors, including tumor-associated macrophages (TAMs) and regulatory T cells (Tregs), always lead to immunotherapy failure because they limit T cell infiltration
Immunogenic cell death (ICD) has aroused widespread attention because it can reconstruct a tumor microenvironment and activate antitumor immunity. This study proposes a two-way enhancement of ICD based on aCaO 2 @CuS-MnO 2 @HA (CCMH) nanocomposite to overcome the insufficient damageassociated molecular patterns (DAMPs) of conventional ICD-inducers. The near-infrared (NIR) irradiation (1064 nm) of CuS nanoparticles generates 1 O 2 through photodynamic therapy (PDT) to trigger ICD, and it also damages the Ca 2+ buffer function of mitochondria. Additionally, CaO 2 nanoparticles react with H 2 O to produce a large amount of O 2 and Ca 2+ , which respectively lead to enhanced PDT and Ca 2+ overload during mitochondrial damage, thereby triggering a robust ICD activation. Moreover, oxidative-damaged mitochondrial DNA, induced by PDT and released from tumor cells, reprograms the immunosuppressive tumor microenvironment by transforming tumor-associated macrophages to the M1 subphenotype. This study shows that CCMH with NIR-II irradiation can elicit adequate DAMPs and an active tumorimmune microenvironment for both 4T1 and CT26 tumor models. Combining this method with an immune checkpoint blockade can realize an improved immunotherapy efficacy and long-term protection effect for body.